BT Lab
SKU:BT-AP14598
SV2A Polyclonal Antibody
SV2A Polyclonal Antibody
Couldn't load pickup availability
The protein encoded by this gene is one of three related synaptic vesicle proteins. The encoded protein may interact with synaptotagmin to enhance low frequency neurotransmission in quiescent neurons.
Introducing the SV2A Polyclonal Antibody, a cutting-edge biotechnological solution designed to revolutionize the field of neuroscience research. This meticulously crafted antibody is specifically engineered to target the synaptic vesicle glycoprotein 2A (SV2A), a crucial protein involved in neurotransmitter release and synaptic vesicle trafficking.
The SV2A Polyclonal Antibody boasts exceptional specificity and sensitivity, enabling researchers to accurately detect and quantify SV2A expression levels in various biological samples. Its high affinity for SV2A ensures reliable and reproducible results, facilitating precise investigations into the intricate mechanisms underlying synaptic transmission and neurological disorders.
Crafted with utmost precision, this antibody undergoes rigorous quality control measures to guarantee optimal performance and consistency. Its polyclonal nature allows for enhanced versatility, enabling researchers to employ a wide range of techniques such as immunohistochemistry, immunofluorescence, and Western blotting, among others.
With its advanced formulation, the SV2A Polyclonal Antibody exhibits exceptional stability and longevity, ensuring prolonged shelf life and reliable results throughout the course of experiments. Its user-friendly design and comprehensive instructions enable seamless integration into existing laboratory protocols, minimizing any potential disruptions to workflow.
The SV2A Polyclonal Antibody represents a breakthrough in neuroscience research, offering researchers an invaluable tool to unravel the complexities of synaptic function and neurological disorders. With its unparalleled specificity, sensitivity, and versatility, this antibody is poised to drive scientific advancements and pave the way for novel therapeutic interventions in the realm of neuroscience.
Share
